Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. .
ADMA Biologics, Inc.February 26, 2021 GMT
Poster Presentation Highlights the Need for a Polyclonal Hyperimmune Globulin Targeting S. Pneumoniae
to Bridge Vaccination and Seroconversion Across Multiple Serotypes
By Using as an Add-On with a Vaccine or Antibiotics, This Therapeutic Strategy has the Potential to Improve S. Pneumoniae
-Related Hospital Clinical Outcomes
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 26, 2021 (GLOBE NEWSWIRE) ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the presentation of a late-breaking poster at the 2021 American Academy of Allergy, Asthma & Immunology Conference (“AAAAI”) Virtu
Submit Full Proposals for NGO Programs Benefiting Refugees and Vulnerable Populations in Burkina Faso, Mauritania, Niger, and Senegal 2021
fundsforngos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fundsforngos.org Daily Mail and Mail on Sunday newspapers.
Session Dates: Friday, February 26 – Monday, March 1, 2021
Session Location: Virtual Poster Hall
Poster No: L30
About ADMA Biologics, Inc.
ADMA Biologics is an end-to-end American commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globu
The Biden administration announced Wednesday it will send more than 25 million masks to more than 1,300 community health centers and 60,000 food pantries and soup kitchens in order to reach some Americans most vulnerable to COVID-19. Why it matters: Many studies show wearing tightly fit masks, and even double-masking, is effective to curb the spread of COVID-19 when social distancing is not possible.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeDetails: Masks will be free to recipients, made out of well-fitting cloth in children's and adult sizes and can be washed for reuse.The federal government will pay $86 million for the American-made masks.The administration is taking the more targeted move to send to vulnerable populations after considering whether to send masks to all Americans, a notion that’s been shelved for now, Bloomberg first reported. The big picture: Despite declines in coronavirus cases and deaths and inc